State of Minnesota by its Attorney General, Keith Ellison v. JUUL Labs, Inc. et al, 27-CV-19-19888: Part of the trial team in the State of Minnesota litigation against e-cigarette manufacturer JUUL and Altria for deceptively marketing tobacco products and targeting Minnesota’s youth. After a three-week trial, which settled prior to closing arguments, JUUL and Altria were ordered to pay a total of $60.5 million to the State of Minnesota over an eight-year period. This settlement is the largest per capita of all 48 states and territories that have settled with JUUL. Minnesota was the first state in the nation to go to trial.

McDougall v. CRC Industries, Inc. et al, 0:20-cv-01499-JRT-LIB: Part of the trial team that helped secure a landmark $7.75 million verdict against CRC Industries for its failure to prevent the foreseeable misuse of its aerosol dust remover products. The verdict follows the 2019 death of Cynthia McDougall, who was killed in a vehicle crash after an individual who huffed CRC Duster struck her car head-on. This is the first dust remover case of its kind to go to trial.

In re: Benicar (Olmesartan Medoxomil) Products Liability Litigation, MDL No. 2606 (New Jersey) and NJ MCL Case No. 299: Actively participated in the Benicar (Olmesartan) Multi-District Litigation. The MDL reached a global $358 million settlement.

In re: Abilify (Aripiprazole) Product Liability Litigation, MDL No. 2734 (Northern District of Florida) and NJ MCL Case No. 626: Abilify is a prescription drug approved for use in the U.S. by the Food and Drug Administration (FDA) to treat mental health conditions. The drug also allegedly caused some patients to gamble uncontrollably, along with other compulsive behaviors. A confidential settlement was obtained in 2019.

In re: Taxotere (Docetaxel), MDL No. 2740 (Eastern District of Louisiana) and NJ MCL Case No. 628: Taxotere is a chemotherapy drug used to treat breast cancer.  The treatment is the only drug in its class that can cause permanent alopecia.